Patents Assigned to Boston Scientific Neuromodulation Corporation
  • Patent number: 10357657
    Abstract: An electrical stimulation system includes a control module that provides electrical stimulation signals to an electrical stimulation lead coupled to the control module for stimulation of patient tissue. The system also includes a sensor to be disposed on or within the body of the patient and to measure a biosignal; and a processor to communicate with the sensor to receive the biosignal and to generate an adjustment to one or more of the stimulation parameters based on the biosignal. The adjustment can be configured and arranged to steer the electrical stimulation signals to stimulate a region of the patient tissue that is different, at least in part, from a region of the patient tissue stimulated prior to the adjustment. Alternatively or additionally, the biosignal is indicative of a particular patient activity and the adjustment is a pre-determined adjustment selected for the particular patient activity.
    Type: Grant
    Filed: April 17, 2018
    Date of Patent: July 23, 2019
    Assignee: BOSTON SCIENTIFIC NEUROMODULATION CORPORATION
    Inventors: Michael A. Moffitt, Sridhar Kothandaraman
  • Patent number: 10357652
    Abstract: A method for implanting a neurostimulation lead within a patient includes measuring impedances of electrodes on the lead in order to correctly position the lead relative to a target tissue region. The electrodes are circumferentially segmented electrodes that are spaced from each other about the longitudinal axis of the lead. When the difference between the impedances of the electrodes exceeds a threshold value, the lead is in the correct position. In accordance with another embodiment, impedance measurements are used to select which one of the electrodes is closest to the target tissue region. By determining which electrode has the highest impedance and which electrode has the lowest impedance, the type of tissue adjacent to each electrode can be determined based on the conductivity properties of the tissue. The target tissue region may be a spinal cord, a posterior longitudinal ligament, white matter, or gray matter.
    Type: Grant
    Filed: May 31, 2018
    Date of Patent: July 23, 2019
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventor: Kerry Bradley
  • Patent number: 10350404
    Abstract: Method and systems for determining a set of stimulation parameters for an implantable stimulation device include receiving a set of stimulation parameters including at least one electrode for delivery of stimulation and a stimulation amplitude for each electrode; determining, using the set of stimulation parameters, an axial stimulation field for neural elements oriented axially with respect to a longitudinal axis of the lead; and outputting the first axial stimulation field for viewing by a user; receiving, by the computer processor. The methods and systems can be used to model other neural elements oriented non-orthogonally with respect to the longitudinal axis of the lead and determine a non-orthogonal stimulation field.
    Type: Grant
    Filed: August 29, 2017
    Date of Patent: July 16, 2019
    Assignee: BOSTON SCIENTIFIC NEUROMODULATION CORPORATION
    Inventors: Tianhe Zhang, G. Karl Steinke, Richard Mustakos
  • Patent number: 10350413
    Abstract: A computer implemented system and method generates a patient-specific model of patient response to stimulation on a neural element basis, receives user-input of target neuromodulation sites, and, based on the patient-specific model, determines which stimulation paradigm and settings, including stimulation sites, would result in the target neuromodulation, where the stimulation sites are not necessarily the same as the resulting neuromodulation sites. The system outputs a visual representation of the stimulation sites that would result in the target neuromodulation. The system monitors a system state and/or patient state and dynamically changes which stimulation program to implement based on the state.
    Type: Grant
    Filed: January 17, 2017
    Date of Patent: July 16, 2019
    Assignee: BOSTON SCIENTIFIC NEUROMODULATION CORPORATION
    Inventors: Michael A. Moffitt, Rafael Carbunaru
  • Patent number: 10352776
    Abstract: Temperature sensing circuitry for an Implantable Medical Device (IMD) is disclosed that can be integrated into integrated circuitry in the IMD and draws very little power, thus enabling continuous temperature monitoring without undue battery depletion. Temperature sensor and threshold setting circuitry produces analog voltage signals indicative of a sensed temperature and at least one temperature threshold. Such circuitry employs a Ptat current reference stage and additional stages, which stages contains resistances that are set based on the desired temperature threshold(s) and to set the voltage range of the sensed temperature. These analog voltages are received at temperature threshold detection circuitry, which produces digital signal(s) indicating whether the sensed temperature has passed the temperature threshold(s). The digital signal(s) are then provided to digital circuitry in the IMD, where they can be stored as a function of time for later review, or used to immediately to control IMD operation.
    Type: Grant
    Filed: March 20, 2018
    Date of Patent: July 16, 2019
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Emanuel Feldman, Goran N. Marnfeldt
  • Patent number: 10350420
    Abstract: Improved external chargers for charging an implantable medical device, and particularly useful in charging a plurality of such devices, are disclosed. Each of the various embodiments include a plurality of field customization coils for customizing the magnetic charging field generated by the external charger such that the magnetic charging field is not radially symmetric. For example, one embodiment includes a primary coil with a plurality of field customization coils distributed radially with respect to the coil. The generated magnetic charging field can be rendered radially asymmetric by selectively activating or disabling the field customization coils in response to data quantifying the coupling between the various implants and the field customization coils in the charger.
    Type: Grant
    Filed: June 6, 2017
    Date of Patent: July 16, 2019
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Rafael Carbunaru, Andrew DiGiore, Todd Whitehurst
  • Patent number: 10342983
    Abstract: A connector for an implantable electrical medical device can include a connector housing having a first portion and a second portion that can partially separate to receive a lead or lead extension into a connector lumen of the connector housing. The connector also includes at least one connector magnetic element coupled to each of the first and second portions of the connector housing to couple to at least one corresponding magnetic element in the lead or lead extension to align the lead or lead extension within the connector lumen of the connector housing. An electrical stimulation lead can include at least one lead magnetic element disposed along the proximal end of the lead body to couple to at least one corresponding magnetic element in a connector to align the lead within a connector lumen of the connector.
    Type: Grant
    Filed: January 10, 2017
    Date of Patent: July 9, 2019
    Assignee: BOSTON SCIENTIFIC NEUROMODULATION CORPORATION
    Inventors: Ranjan Krishna Mukhari Nageri, Geoffrey Abellana Villarta, Anne M. Pianca
  • Patent number: 10342984
    Abstract: A charging system for an Implantable Medical Device (IMD) includes a split charging coil for generating a magnetic field to provide power to the IMD. The split charging coil includes a first coil portion and a second coil portion, each of which can be formed as a mechanical winding of an insulated conductor. The first and second coil portions are connected to each other in a way that substantially reduces or eliminates any current-carrying path that is routed radially with respect to the coil. As a result, the split coil produces a uniform magnetic field that enables a more accurate determination of alignment between the coil and the IMD than is available using traditional charging coils.
    Type: Grant
    Filed: June 7, 2017
    Date of Patent: July 9, 2019
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventor: Thomas W. Stouffer
  • Patent number: 10342972
    Abstract: A system and method may include determining a target stimulation volume based on modifying a patient population image for which an efficacious volume had been determined. A system and method for suggesting stimulation devices may include determining which stimulation device is capable of producing an output volume of activation that most closely matches the target volume. A system and method for facilitating selection of stimulation parameters may include graphically identifying a maximum volume in which tissue is stimulatable by an implanted stimulation device. A system and method may pre-compute volumes of activation that result from a predetermined modification of programming settings. A system and method may transmit stimulation programming settings from a stimulation programming module to a stimulation generating device.
    Type: Grant
    Filed: April 11, 2016
    Date of Patent: July 9, 2019
    Assignee: BOSTON SCIENTIFIC NEUROMODULATION CORPORATION
    Inventors: David Arthur Blum, Scott Kokones, Michael A. Moffitt, Jordan Barnhorst, Keith Carlton
  • Patent number: 10342979
    Abstract: An example of a system may include electrodes on at least one lead configured to be operationally positioned for use in modulating neural tissue. The neural tissue may include at least one of dorsal horn tissue, dorsal root tissue or dorsal column tissue. The system may include an implantable device including a neural modulation device and a controller. The neural modulation device may be configured to use at least some of the electrodes to generate a modulation field to deliver sub-perception modulation to the neural tissue. The sub-perception modulation may have an intensity below a patient-perception threshold. The patient-perception threshold may be a boundary below which a patient does not sense generation of the modulation field. The controller may be configured to control the neural modulation device to generate the modulation field, and automatically adjust the modulation field in response to a patient input.
    Type: Grant
    Filed: May 9, 2018
    Date of Patent: July 9, 2019
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Jordi Parramon, Bradley Lawrence Hershey, Michael A. Moffitt, Changfang Zhu
  • Patent number: 10335601
    Abstract: A neurostimulation system includes a programming control circuit and a user interface. The programming control circuit may be configured to generate a plurality of stimulation parameters controlling delivery of neurostimulation pulses according to one or more neurostimulation programs each specifying a pattern of the neurostimulation pulses. The user interface includes a display screen, a user input device, and a neurostimulation program circuit. The neurostimulation program circuit may be configured to allow for construction of one or more pulse trains (PTs) and one or more train groupings (TGs) of the one or more neurostimulation programs, and to allow for scheduling of delivery of the one or more neurostimulation programs, using the display screen and the user input device. Each PT includes one or more pulse blocks each including a plurality of pulses of the neurostimulation pulses. Each TG includes one or more PTs.
    Type: Grant
    Filed: June 13, 2016
    Date of Patent: July 2, 2019
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventor: David Ernest Wechter
  • Patent number: 10335607
    Abstract: An optical stimulation lead includes a lead body including a distal end, a distal portion, and a proximal portion; and an optical assembly attached to the distal end of the lead body. The optical assembly includes a light emitter; a feedthrough assembly including at least one ceramic block, at least one feedthrough pin extending through the at least one ceramic block and electrically coupled to the light emitter, and a metal housing attached to the at least one ceramic block; a metal tube attached to the feedthrough assembly and disposed around the light emitter; and an emitter cover disposed over the light emitter and coupled to the metal tube.
    Type: Grant
    Filed: January 31, 2017
    Date of Patent: July 2, 2019
    Assignee: BOSTON SCIENTIFIC NEUROMODULATION CORPORATION
    Inventor: William George Orinski
  • Patent number: 10335599
    Abstract: An example of a neurostimulation system may include a storage device to store a stimulation waveform, a programming control circuit to generate a plurality of stimulation parameters controlling delivery of neurostimulation pulses according to the stimulation waveform, and waveform definition circuit configured to create and adjust the stimulation waveform. The waveform definition circuit includes a charge recovery module that may include a stimulation to receive the stimulation waveform including charge injection phases, a charge recovery scheme input to receive a charge recovery scheme, and a waveform adjuster configured to identify a need for recovering charges injected during the charge injection phases and adjust the received stimulation waveform by automatically inserting charge recovery phases into the received stimulation waveform based on the identified need for recovering the injected charges and the received charge recovery scheme.
    Type: Grant
    Filed: August 7, 2017
    Date of Patent: July 2, 2019
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventor: Dennis Zottola
  • Patent number: 10335602
    Abstract: A holder for an implantable medical device (IMD) is disclosed. The holder is configured to hold the IMD in a single, operational orientation when the holder containing the IMD is implanted in a patient. The holder is designed to prevent the IMD from moving within the patient and shifting orientation. The holder may have an opening for receiving a connecting pin, for stimulating electrodes, for example, in a mating orientation with respect to a receptacle contained within the IMB. According to some embodiments, the IMB features a metal housing that can serve as an electrode and the holder is configured with a window to allow a portion of the housing to electrically contact flesh of a patient during operation. Holders for containing a single IMD and holders for containing multiple IMDs are disclosed. Holders for containing multiple IMDs are configured to maintain alignment of the IMDs with respect to each other, for example, a parallel alignment.
    Type: Grant
    Filed: June 23, 2017
    Date of Patent: July 2, 2019
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Matthew Lee McDonald, Jillian Doubek, Samuel Tahmasian
  • Patent number: 10328265
    Abstract: An example of a system may include an arrangement of electrodes configured to be operationally positioned for use in modulating targeted neural tissue, a neural modulator, a communication module, and a controller. The neural modulator may be configured to use at least some electrodes within the arrangement of electrodes to generate a modulation field. The communication module may be configured to receive user-provided selections. The controller may be configured to use the communication module to receive a user-provided selection of a desired electrode list where the electrode list identifies electrodes within the arrangement of electrodes that are available for use in modulating the targeted neural tissue, control the neural stimulation modulator to generate the modulation field, and use the electrodes identified in the electrode list to modulate the targeted neural tissue.
    Type: Grant
    Filed: May 22, 2017
    Date of Patent: June 25, 2019
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Michael A. Moffitt, Bradley Lawrence Hershey, Changfang Zhu, Jordi Parramon, Sridhar Kothandaraman
  • Patent number: 10315038
    Abstract: An example of a system may include a processor and a memory device comprising instructions, which when executed by the processor, cause the processor to receive, in a graphical user interface, a clinician input of physiological information and therapy information for neurostimulation treatment of a human subject using a neurostimulation device, and request a neurostimulation program corresponding to the physiological information and the therapy information from a remote programming guidance information system. For example, program data of a neurostimulation program may be provided from the programming guidance information system, selected on the basis of a best match to the physiological information and the therapy information.
    Type: Grant
    Filed: February 15, 2017
    Date of Patent: June 11, 2019
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventor: Annasaheb Suryavanshi
  • Patent number: 10307593
    Abstract: A neuromodulation system executes a set of startup operations. In response to completion of the startup operations, a priming field is automatically initiated. The priming field is to produce a priming effect in priming-targeted neural tissue, with the priming effect causing a change in sensitization to a therapeutic neuromodulation field of the priming-targeted neural tissue. The system also generates the therapeutic neuromodulation field to produce a therapeutic effect in therapy-targeted neural tissue.
    Type: Grant
    Filed: June 1, 2017
    Date of Patent: June 4, 2019
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Que T. Doan, Bradley Lawrence Hershey, Changfang Zhu
  • Patent number: 10307602
    Abstract: A connector assembly includes a lead with a lead body having proximal and distal portions. The lead body defines a longitudinal axis. Terminals are disposed along the proximal portion and a proximal tip is attached thereto. The proximal tip defines an aperture that is non-parallel to the longitudinal axis. The connector assembly further includes a connector having a connector body, a connector lumen, and connector contacts disposed within the connector body. The connector body includes a fastener aperture proximal to all of the connector contacts and intersecting the connector lumen. The fastener aperture and the aperture of the proximal tip align when the proximal portion is fully received within the connector lumen. At least one of the apertures includes internal threading. The connector assembly also includes a threaded fastener for insertion into the apertures to secure the lead to the connector.
    Type: Grant
    Filed: July 5, 2017
    Date of Patent: June 4, 2019
    Assignee: BOSTON SCIENTIFIC NEUROMODULATION CORPORATION
    Inventor: Jacob B. Leven
  • Patent number: 10307595
    Abstract: A therapeutic neuromodulation system configured for providing therapy to a patient. The therapeutic neuromodulation system comprises a plurality of electrical terminals configured for being respectively coupled to a plurality of electrodes implanted within tissue, analog output circuitry configured for delivering therapeutic electrical energy between the plurality of electrical terminals in accordance with a set of modulation parameters that includes a defined current value, a voltage regulator configured for supplying an adjustable compliance voltage to the analog output circuitry, and control/processing circuitry configured for automatically performing a compliance voltage calibration process at a compliance voltage adjustment interval by periodically computing an adjusted compliance voltage value as a function of a compliance voltage margin.
    Type: Grant
    Filed: February 1, 2017
    Date of Patent: June 4, 2019
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Jess Weiqian Shi, Jordi Parramon, Goran N. Marnfeldt
  • Patent number: 10299783
    Abstract: A system and method for securing a medical implant within a patient. The method includes disposing an anchor element around the implant, the anchor element including a pair of tabs each including an eyelet, and a flexible intermediate portion between the tabs, wherein disposing the anchor element around the implant includes positioning the implant within the intermediate portion and folding the anchor element such that the tabs contact one another and the eyelets aligned. The anchor element is positioned at a desired implantation position with the tabs positioned proximate soft tissue of the patient. The method further includes inserting a distal tip of a fixation element delivery tool through the eyelets and into the soft tissue, the fixation element including at least one tissue anchor and an adjustable suture arrangement coupled to the tissue anchor. The at least one tissue anchor is deployed from the delivery tool and into the soft tissue of the patient.
    Type: Grant
    Filed: December 19, 2016
    Date of Patent: May 28, 2019
    Assignee: BOSTON SCIENTIFIC NEUROMODULATION CORPORATION
    Inventors: Lawrence W. Wales, Jeffrey J. Peters, Vic Fabano, Ishmael Bentley